|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Szkandera J, Pichler M, Absenger G, Stotz
M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H,
Kornprat P, Stojakovic T, et al: The elevated preoperative platelet
to lymphocyte ratio predicts decreased time to recurrence in colon
cancer patients. Am J Surg. 208:210–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
DeNardo DG and Coussens LM: Inflammation
and breast cancer. Balancing immune response: Crosstalk between
adaptive and innate immune cells during breast cancer progression.
Breast Cancer Res. 9:2122007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim
KH and Kim HJ: Prognostic significance of neutrophil lymphocyte
ratio and platelet lymphocyte ratio in advanced gastric cancer
patients treated with FOLFOX chemotherapy. BMC Cancer. 13:3502013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Asher V, Lee J, Innamaa A and Bali A:
Preoperative platelet lymphocyte ratio as an independent prognostic
marker in ovarian cancer. Clin Transl Oncol. 13:499–503. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krenn-Pilko S, Langsenlehner U, Thurner
EM, Stojakovic T, Pichler M, Gerger A, Kapp KS and Langsenlehner T:
The elevated preoperative platelet-to-lymphocyte ratio predicts
poor prognosis in breast cancer patients. Br J Cancer.
110:2524–2530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Azab B, Shah N, Radbel J, Tan P, Bhatt V,
Vonfrolio S, Habeshy A, Picon A and Bloom S: Pretreatment
neutrophil/lymphocyte ratio is superior to platelet/lymphocyte
ratio as a predictor of long-term mortality in breast cancer
patients. Med Oncol. 30:4322013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu H, Wu Y, Wang Z, Yao Y, Chen F, Zhang
H, Wang Y and Song Y: Pretreatment platelet-to-lymphocyte ratio
(PLR) as a predictor of response to first-line platinum-based
chemotherapy and prognosis for patients with non-small cell lung
cancer. J Thorac Dis. 5:783–789. 2013.PubMed/NCBI
|
|
12
|
Feng JF, Huang Y and Chen QX: Preoperative
platelet lymphocyte ratio (PLR) is superior to neutrophil
lymphocyte ratio (NLR) as a predictive factor in patients with
esophageal squamous cell carcinoma. World J Surg Oncol. 12:582014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng JF, Huang Y, Zhao Q and Chen QX:
Clinical significance of preoperative neutrophil lymphocyte ratio
versus platelet lymphocyte ratio in patients with small cell
carcinoma of the esophagus. Scientific World Journal.
2013:5043652013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang N, Deng JY, Liu Y, Ke B, Liu HG and
Liang H: The role of preoperative neutrophil-lymphocyte and
platelet-lymphocyte ratio in patients after radical resection for
gastric cancer. Biomarkers. 19:444–451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai Q, Castro Santa E, Rico Juri JM,
Pinheiro RS and Lerut J: Neutrophil and platelet-to-lymphocyte
ratio as new predictors of dropout and recurrence after liver
transplantation for hepatocellular cancer. Transpl Int. 27:32–41.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu H, Du X, Sun P, Xiao C, Xu Y and Li R:
Preoperative platelet-lymphocyte ratio is an independent prognostic
factor for resectable colorectal cancer. Nan Fang Yi Ke Da Xue Xue
Bao. 33:70–73. 2013.(In Chinese). PubMed/NCBI
|
|
17
|
He W, Yin C, Guo G, Jiang C, Wang F, Qiu
H, Chen X, Rong R, Zhang B and Xia L: Initial neutrophil lymphocyte
ratio is superior to platelet lymphocyte ratio as an adverse
prognostic and predictive factor in metastatic colorectal cancer.
Med Oncol. 30:4392013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kwon HC, Kim SH, Oh SY, Lee S and Lee JH,
Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ and Lee JH: Clinical
significance of preoperative neutrophil-lymphocyte versus
platelet-lymphocyte ratio in patients with operable colorectal
cancer. Biomarkers. 17:216–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th). New York,
NY: Springer. 143–164. 2010.
|
|
20
|
National Comprehensive Cancer Network:
NCCN Clinical Practice Guidelines in Oncology: Colon Cancer.
Version 1. National Comprehensive Cancer Network (Washington).
2015.
|
|
21
|
National Comprehensive Cancer Network:
NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer.
Version 1. National Comprehensive Cancer Network (Washington).
2015.
|
|
22
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Waldner MJ and Neurath MF:
Colitis-associated cancer: The role of T cells in tumor
development. Semin Immunopathol. 31:249–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim
KH, Goh RY, Choi HJ, Park KJ, Roh MS, et al: Clinical significance
of preoperative serum vascular endothelial growth factor,
interleukin-6, and C-reactive protein level in colorectal cancer.
BMC Cancer. 10:2032010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA,
Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, et al: Clinical
significances of preoperative serum interleukin-6 and C-reactive
protein level in operable gastric cancer. BMC Cancer. 9:1552009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chiang SF, Hung HY, Tang R, Changchien CR,
Chen JS, You YT, Chiang JM and Lin JR: Can neutrophil-to-lymphocyte
ratio predict the survival of colorectal cancer patients who have
received curative surgery electively? Int J Colorectal Dis.
27:1347–1357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nieswandt B, Aktas B, Moers A and Sachs
UJ: Platelets in atherothrombosis: Lessons from mouse models. J
Thromb Haemost. 3:1725–1736. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goubran HA, Stakiw J, Radosevic M and
Burnouf T: Platelets effects on tumor growth. Semin Oncol.
41:359–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sharma D, Brummel-Ziedins KE, Bouchard BA
and Holmes CE: Platelets in tumor progression: A host factor that
offers multiple potential targets in the treatment of cancer. J
Cell Physiol. 229:1005–1015. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Templeton AJ, Ace O, McNamara MG,
Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A,
Tannock IF and Amir E: Prognostic role of platelet to lymphocyte
ratio in solid tumors: A systematic review and meta-analysis.
Cancer Epidemiol Biomarkers Prev. 23:1204–1212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Salazar-Onfray F, López MN and
Mendoza-Naranjo A: Paradoxical effects of cytokines in tumor immune
surveillance and tumor immune escape. Cytokine Growth Factor Rev.
18:171–182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishizuka M, Nagata H, Takagi K, Iwasaki Y
and Kubota K: Combination of platelet count and neutrophil to
lymphocyte ratio is a useful predictor of postoperative survival in
patients with colorectal cancer. Br J Cancer. 109:401–407. 2013.
View Article : Google Scholar : PubMed/NCBI
|
